Heron Capital is a private investment partnership with a focus on niche manufacturing and healthcare. Heron Capital’s first investment vehicle is Heron Capital Venture Fund (the Fund). The Fund is an early stage investor focused on medical devices, diagnostics and tools, and is fully deployed. Heron Capital’s current investment vehicle is Heron Capital Equity Partners (HCEP). HCEP seeks to invest in, acquire or recapitalize small to middle market companies.
HCEP is not a private equity fund; rather, we are a group of professional investors and operators investing our own money to acquire private companies. We are not shackled by fund investment periods and are free to hold and operate our companies for as long as necessary to maximize value for all shareholders.
AirXpanders Announces First Commercial U.S. Procedure for AeroForm® Tissue Expander System for Breast Reconstruction
January 18, 2017
US FDA grants de novo clearance to AirXpanders' AeroForm Tissue Expander System for breast reconstruction
December 26, 2016
First Patient Treated in U.S. Randomized Trial of NeoChord’s, Off-Pump, Minimally Invasive Repair for Degenerative Mitral Regurgitation
November 9, 2016